Quality of Animal Experiments in Anti-Angiogenic Cancer Drug Development--A Systematic Review.
Translation from preclinical animal research to clinical bedside has proven to be difficult to impossible in many fields of research (e.g. acute stroke, ALS and HIV vaccination development) with oncology showing particularly low translation rates (5% vs. 20% for cardiovascular diseases). Several inv...
Saved in:
| Main Authors: | Marianne Isabelle Martić-Kehl, Jannis Wernery, Gerd Folkers, Pius August Schubiger |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0137235 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Changes in vascular permeability and expression of different angiogenic factors following anti-angiogenic treatment in rat glioma.
by: Meser M Ali, et al.
Published: (2010-01-01) -
Anti-angiogenic and anti-inflammatory properties of kahweol, a coffee diterpene.
by: Casimiro Cárdenas, et al.
Published: (2011-01-01) -
ROS-responsive drug delivery system with enhanced anti-angiogenic and anti-inflammatory properties for neovascular age-related macular degeneration therapy
by: Jiayi Zuo, et al.
Published: (2025-06-01) -
Aberrant angiogenic signaling in HCC: therapeutic targeting and drug resistance
by: Hongtao Zhang, et al.
Published: (2025-06-01) -
Clinical Implication of Anti-Angiogenic Effect of Regorafenib in Metastatic Colorectal Cancer.
by: Yoojoo Lim, et al.
Published: (2015-01-01)